Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Intellia Therapeutics
NTLA
$1.49B
| $17.7M | ﹤0.01% |
789,831
+61,536
| +8% | +$1.47M |
|
1752
Chefs' Warehouse
CHEF
$4.71B
| $17.7M | ﹤0.01% |
451,353
+10,951
| +2% | +$405K |
|
1753
Caleres
CAL
$431M
| $17.6M | ﹤0.01% |
523,133
+3,531
| +0.7% | +$127K |
|
1754
Avis
CAR
$4.86B
| $17.6M | ﹤0.01% |
168,135
+10,468
| +7% | +$1.17M |
|
1755
Rhythm Pharmaceuticals
RYTM
$6.81B
| $17.6M | ﹤0.01% |
427,958
+21,213
| +5% | +$847K |
|
1756
Braze
BRZE
$2.81B
| $17.6M | ﹤0.01% |
452,054
+41,870
| +10% | +$1.67M |
|
1757
Palomar
PLMR
$3.55B
| $17.5M | ﹤0.01% |
216,043
+7,300
| +3% | +$595K |
|
1758
Mercury Systems
MRCY
$5.83B
| $17.5M | ﹤0.01% |
649,251
+160,341
| +33% | +$4.68M |
|
1759
The Bancorp
TBBK
$2.79B
| $17.5M | ﹤0.01% |
463,594
+4,028
| +0.9% | +$133K |
|
1760
Green Brick Partners
GRBK
$3.04B
| $17.5M | ﹤0.01% |
305,537
+49,941
| +20% | +$2.79M |
|
1761
Surgery Partners
SGRY
$2.01B
| $17.5M | ﹤0.01% |
733,936
+76,143
| +12% | +$1.95M |
|
|
DCH
1762
Dauch Corp
DCH
$1.34B
| $17.5M | ﹤0.01% |
2,497,018
-435,968
| -15% | -$3.22M |
|
|
PENG
1763
Penguin Solutions Inc
PENG
$2.7B
| $17.4M | ﹤0.01% |
762,853
+41,561
| +6% | +$865K |
|
|
REVG
1764
DELISTED
REV Group
REVG
| $17.4M | ﹤0.01% |
698,091
-102,822
| -13% | -$2.52M |
|
1765
Privia Health
PRVA
$2.98B
| $17.4M | ﹤0.01% |
999,072
+73,221
| +8% | +$1.3M |
|
|
ACLX
1766
DELISTED
Arcellx
ACLX
| $17.3M | ﹤0.01% |
313,893
+31,883
| +11% | +$1.73M |
|
|
CPRX
1767
DELISTED
Catalyst Pharmaceutical
CPRX
| $17.3M | ﹤0.01% |
1,116,939
+41,380
| +4% | +$644K |
|
1768
DigitalOcean
DOCN
$13.7B
| $17.2M | ﹤0.01% |
495,063
+67,091
| +16% | +$2.39M |
|
|
CSGS
1769
DELISTED
CSG Systems International
CSGS
| $17.2M | ﹤0.01% |
417,472
+31,371
| +8% | +$1.39M |
|
1770
Ichor Holdings
ICHR
$2.62B
| $17.2M | ﹤0.01% |
445,806
+51,113
| +13% | +$1.95M |
|
1771
Safety Insurance
SAFT
$1.52B
| $17.2M | ﹤0.01% |
228,760
+5,563
| +2% | +$437K |
|
1772
Astrana Health
ASTH
$1.76B
| $17.1M | ﹤0.01% |
422,489
+36,719
| +10% | +$1.46M |
|
1773
Enterprise Financial Services Corp
EFSC
$2.4B
| $17.1M | ﹤0.01% |
418,288
+22,237
| +6% | +$864K |
|
1774
Descartes Systems
DSGX
$6.44B
| $17.1M | ﹤0.01% |
+176,457
| New | +$16.6M |
|
1775
Ambarella
AMBA
$3.77B
| $17.1M | ﹤0.01% |
316,619
+10,689
| +3% | +$531K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.